Zinc ointment (Ointment) Instructions for Use
ATC Code
D02AB (Zinc preparations)
Active Substance
Zinc oxide (Ph.Eur. European Pharmacopoeia)
Clinical-Pharmacological Group
Drug with astringent and drying action for external use
Pharmacotherapeutic Group
Preparations with emollient and protective action. Zinc preparations
Pharmacological Action
Zinc oxide exerts a drying, adsorbent, astringent, and disinfectant action.
It reduces exudation and weeping, which alleviates local inflammatory phenomena and irritation.
Indications
“Diaper” rash, intertrigo, miliaria, dermatitis, ulcerative skin lesions, superficial wounds, and burns.
ICD codes
| ICD-10 code | Indication |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L22 | Diaper dermatitis |
| L23 | Allergic contact dermatitis |
| L24 | Irritant contact dermatitis |
| L25 | Unspecified contact dermatitis |
| L30.0 | Nummular eczema |
| L30.4 | Erythematous intertrigo |
| L30.9 | Dermatitis, unspecified |
| L74.3 | Unspecified miliaria |
| L89 | Decubitus ulcer and pressure area |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T30 | Burns and corrosions of unspecified body region |
| ICD-11 code | Indication |
| 9A06.70 | Atopic eczema of the eyelids |
| EA40 | Tropical phagedenic ulcer |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EA85.20 | Atopic hand eczema |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EF60 | Ischemic ulceration of the skin |
| EH40.10 | Diaper dermatitis |
| EH90.Z | Pressure ulcer of unspecified degree |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EK00.Z | Allergic contact dermatitis, unspecified |
| EK02.20 | Intertriginous dermatitis due to friction, sweating or contact with body fluids |
| EK02.Z | Irritant contact dermatitis, unspecified |
| EK5Y | Other specified skin lesions provoked by exposure to external factors |
| EM0Z | Unspecified skin disorder |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| ND56.0 | Superficial injury of unspecified body region |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For external use only. Apply the ointment 2 to 6 times daily to the affected skin areas. Adjust the frequency of application based on the severity of symptoms and the degree of exudation.
Use a sufficient amount to cover the entire affected area with a thin, uniform layer. The quantity applied is directly proportional to the extent of the lesion.
Prior to application, gently cleanse and thoroughly dry the affected skin area. This ensures optimal contact and efficacy of the preparation.
The ointment can be applied under occlusive dressings, such as a gauze bandage. For diaper dermatitis, apply during each diaper change on clean, dry skin.
For the management of chronic ulcers and pressure sores, apply the ointment after appropriate wound cleansing and debridement, if necessary.
Continue treatment until the acute inflammatory phenomena subside and the skin integrity is restored. Discontinue use if signs of irritation or hypersensitivity appear.
Avoid contact with eyes and mucous membranes. Do not apply to heavily exuding or grossly infected wounds without concurrent antimicrobial therapy.
Adverse Reactions
Allergic reactions such as skin itching, hyperemia, and skin rash are possible.
Contraindications
Hypersensitivity to zinc oxide.
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding is possible according to indications, in the recommended doses.
Pediatric Use
Use in children is possible according to indications, in the recommended doses and dosage forms.
Special Precautions
It is not recommended to use zinc oxide preparations for acute purulent-inflammatory diseases.
Avoid contact of the product with the eyes.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Ointment for external use 10%: tube 30 g
Marketing Authorization Holder
Biosintez, PJSC (Russia)
Dosage Form
 |
Zinc ointment | Ointment for external use 10%: tube 30 g |
Dosage Form, Packaging, and Composition
Ointment for external use homogeneous, from almost white to light yellow in color.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: medical petrolatum – 90 g.
30 g – aluminum tubes (1) – cardboard packs.
30 g – polymer tubes (1) – cardboard packs.
Ointment for external use 10%: 20 g, 25 g, 30 g, or 50 g tubes; 25 g, 30 g, 50 g, or 100 g bottles/jars.
Marketing Authorization Holder
Genel RD, LLC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: 20 g, 25 g, 30 g, or 50 g tubes; 25 g, 30 g, 50 g, or 100 g bottles/jars. |
Dosage Form, Packaging, and Composition
Ointment for external use in the form of a homogeneous mass of white or light yellow color.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: petrolatum – 90 g.
20 g – tubes (1) – cardboard packs.
25 g – tubes (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
50 g – tubes (1) – cardboard packs.
25 g – bottles (1) – cardboard packs.
30 g – bottles (1) – cardboard packs.
50 g – bottles (1) – cardboard packs.
100 g – bottles (1) – cardboard packs.
25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
100 g – jars (1) – cardboard packs.
Ointment for external use 10%: 25 g, 30 g, or 50 g tubes or jars; 100 g jars
Marketing Authorization Holder
Ivanovo Pharmaceutical Factory PJSC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: 25 g, 30 g, or 50 g tubes or jars; 100 g jars |
Dosage Form, Packaging, and Composition
Ointment for external use white or light yellow in color, homogeneous.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: petrolatum – 90 g.
25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
100 g – jars (1) – cardboard packs.
25 g – tubes (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
50 g – tubes (1) – cardboard packs.
Ointment for external use 10%: 25 g or 1.5 kg jars, 30 g tubes, 15 kg bags
Marketing Authorization Holder
Moscow Pharmaceutical Factory CJS (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: 25 g or 1.5 kg jars, 30 g tubes, 15 kg bags |
Dosage Form, Packaging, and Composition
Ointment for external use homogeneous, from white to light yellow in color.
| 1 g | |
| Zinc oxide | 100 mg |
Excipients: petrolatum.
25 g – orange glass jars (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
25 g – orange glass jars – group packaging.
30 g – aluminum tubes – group packaging.
1.5 kg – jars.
15 kg – polyethylene bags (1) – cans.
Ointment for external use 10%: 30 g tube
Marketing Authorization Holder
Patent-Pharm, JSC (Russia)
Manufactured By
Murom Instrument-Making Plant, JSC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: 30 g tube |
Dosage Form, Packaging, and Composition
Ointment for external use in the form of a homogeneous mass from white to light yellow in color.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: petrolatum – up to 100 g.
30 g – tubes – cardboard packs.
Ointment for external use 10%: 20 g, 25 g, 30 g, or 40 g tubes; 25 g or 40 g jars
Marketing Authorization Holder
Tver Pharmaceutical Factory, PJSC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: 20 g, 25 g, 30 g, or 40 g tubes; 25 g or 40 g jars |
Dosage Form, Packaging, and Composition
Ointment for external use in the form of a homogeneous mass from white to light yellow in color.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: petrolatum – 90 g.
20 g – aluminum tubes (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
40 g – aluminum tubes (1) – cardboard packs.
25 g – dark glass jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.
40 g – polyethylene terephthalate jars (1) – cardboard packs.
Ointment for external use 10%: tubes or jars
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: tubes or jars |
Dosage Form, Packaging, and Composition
| Ointment for external use 10% | 1 g |
| Zinc oxide | 100 mg |
25 g – aluminum tubes (1) – paper packs.
25 g – dark glass jars (1) – paper packs.
30 g – aluminum tubes (1) – paper packs.
30 g – dark glass jars (1) – paper packs.
50 g – aluminum tubes (1) – paper packs.
50 g – dark glass jars (1) – paper packs.
Ointment for external use 10%: 25 g, 30 g, or 50 g jars
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: 25 g, 30 g, or 50 g jars |
Dosage Form, Packaging, and Composition
| Ointment for external use 10% | 1 g |
| Zinc oxide | 100 mg |
25 g – polypropylene jars (1) – paper packs.
30 g – polypropylene jars (1) – paper packs.
50 g – polypropylene jars (1) – paper packs.
Ointment for external use 10%: jars or tubes
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: jars or tubes |
Dosage Form, Packaging, and Composition
| Ointment for external use | 1 g |
| Zinc oxide | 100 mg |
Jars (1) – cardboard packs.
Tubes (1) – cardboard packs.
Ointment for external use 10%: 25 g, 30 g, 50 g, or 100 g jars or tubes
Marketing Authorization Holder
Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: 25 g, 30 g, 50 g, or 100 g jars or tubes |
Dosage Form, Packaging, and Composition
Ointment for external use homogeneous, from white to light yellow in color.
| 100 g | |
| Zinc oxide | 10 g |
Excipients: petrolatum – 90 g.
15 g – jars (1) – cardboard packs.
20 g – jars (1) – cardboard packs.
25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
25 g – tubes (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
Tubes from 9 to 300 pcs. – cardboard boxes (for hospitals).
Jars from 9 to 300 pcs. – cardboard boxes (for hospitals).
Ointment for external use 10%: 25 g jar
Marketing Authorization Holder
Yaroslavl Pharmaceutical Factory, CJSC (Russia)
Dosage Form
|
Zinc ointment | Ointment for external use 10%: 25 g jar |
Dosage Form, Packaging, and Composition
| Ointment for external use 10% | 1 g |
| Zinc oxide | 100 mg |
25 g – dark glass jars (1) – cardboard packs.
25 g – dark glass jars.
![Zinc ointment [Ointment] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Zinc ointment [Ointment] 2")